Form D · Biotechnology
IntraBio Inc.
Austin, TX · CIK 0001730493
Offering snapshot reported Mar 25, 2024 · SEC filing
- Reported sold
- $40.3M Offering amount: $41M
- Investors reported
- 37 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 7, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 25, 2024 | Initial | $40,267,575 | No comparison | 37 | SEC filing |
| Nov 5, 2020 | Amendment | $10,300,000 | $5,390,000vs Aug 20, 2018 | 62 | SEC filing |
| Aug 20, 2018 | Initial | $4,910,000 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-508533
Source: Form D, filed Mar 25, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ian Billington | Executive |
| Elizabeth Factor | Director, Executive |
| Mallory Factor | Director, Executive |
| Taylor Fields | Executive |
| Ali Khan | Director |
| Mark Lubkeman | Executive |
| James Meyers | Executive |
| Ian Rosen | Executive |
| Christian C. Yegen | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
201 W 5th Street, Suite 1100
Austin, TX, 78701
Austin, TX, 78701